Avinash Gorakshakar, Market Expert told CNBC-TV18, "In Sun Pharmaceutical Industries partly profit booking is advisable because clearly we have seen this uptrend after a long time and there have been a lot of issues on the Ranbaxy integration. If the holding period is at least for a year, then one can hold on."Sun Pharmaceutical Industries ended at Rs 835.10, up Rs 5.35, or 0.64 percent on the BSE.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
